Você procurou por: fosaprepitanto (Lituano - Inglês)

fosaprepitanto schema
fosaprepitant regimen

atitinkancio 115 mg fosaprepitanto.
115 mg fosaprepitant.

aprepitantas po fosaprepitanto paskyrimo
aprepitant after fosaprepitant administration

viename buteliuke yra fosaprepitanto dimeglumino,
each vial contains fosaprepitant dimeglumine equivalent to

fosaprepitanto poveikis kitų veikliųjų medžiagų farmakokinetikai
effect of fosaprepitant on the pharmacokinetics of other active substances

istirpinus 1 ml tirpalo yra 1 mg fosaprepitanto.
after reconstitution 1 ml of solution contains 1 mg fosaprepitant.

fosaprepitanto farmakokinetika specialių grupių pacientams netirta.
fosaprepitant pharmacokinetics has not been evaluated in special populations.

jaunesni kaip 18 met asmen fosaprepitanto farmakokinetika netirta.
fosaprepitant has not been evaluated in patients below 18 years of age.

ivemend 115 mg milteliai infuziniam tirpalui fosaprepitanto dimegluminas
ivemend 115 mg powder for solution for infusion fosaprepitant dimeglumine

fosaprepitanto farmakologinis poveikis aiškinamas aprepitanto farmakologiniu poveikiu.
the pharmacological effect of fosaprepitant is attributed to aprepitant.

kiekviename flakone yra fosaprepitanto dimeglumino, atitinkančio 150 mg fosaprepitanto.
each vial contains fosaprepitant dimeglumine equivalent to 150 mg fosaprepitant.

ivemend 115 mg milteliai infuziniam tirpalui fosaprepitanto dimegluminas vartoti ven
ivemend 115 mg powder for solution for infusion fosaprepitant dimeglumine intravenous use

ivemend 115 mg milteliai infuziniam tirpalui fosaprepitanto dimegluminas vartoti į veną
ivemend 115 mg powder for solution for infusion fosaprepitant dimeglumine intravenous use

speciali grupi pacient farmakokinetika fosaprepitanto speciali grupi farmakokinetika netirta.
pharmacokinetics in special populations fosaprepitant pharmacokinetics has not been evaluated in special populations.

1 115 mg fosaprepitanto buteliukas 10 po 115 mg fosaprepitanto buteliuk 1 mg/ml
1 vial of 115 mg fosaprepitant 10 vials of 115 mg fosaprepitant 1 mg/ml

vienkartinės fosaprepitanto dozės iki 200 mg apskritai buvo gerai toleruojamos sveikų asmenų.
single doses up to 200 mg of fosaprepitant were generally well tolerated in healthy subjects.

4. 5 skyri) .fosaprepitanto nerekomenduojama vartoti kartu su jonazols preparatais.
concomitant administration of fosaprepitant with st.john 's wort is not recommended.

ištirpinus ir praskiedus, 1 ml tirpalo yra 1 mg fosaprepitanto (1 mg/ml).
after reconstitution and dilution 1 ml of solution contains 1 mg fosaprepitant (1 mg/ml).

rekomenduojama ivemend doz yra 115 mg fosaprepitanto (ivemend) 1-j dien pagal 3-j dien schem.
the recommended dose of ivemend is 115 mg fosaprepitant (ivemend) on day 1 only of a 3-day regimen.

ištirpinus ir praskiedus 1 ml tirpalo yra 1 mg fosaprepitanto (1 mg/ml) (žr. 6.6 skyrių).
after reconstitution and dilution 1 ml of solution contains 1 mg fosaprepitant (1 mg/ml) (see section 6.6).